Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

Introduction. In non-metastatic breast cancer patients, the REMAGUS02 neoadjuvant study was the first to report a significant impact of circulating tumor cells (CTCs) detection by the CellSearch system on the distant metastasis-free survival (DMFS) and overall survival (OS) endpoints. However, these...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidard, François-Clément, Belin, Lisa, Delaloge, Suzette, Lerebours, Florence, Ngo, Charlotte, Reyal, Fabien, Alran, Séverine, Giacchetti, Sylvie, Marty, Michel, Lebofsky, Ronald, Pierga, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665249/
https://www.ncbi.nlm.nih.gov/pubmed/23762567
http://dx.doi.org/10.1155/2013/130470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665249/
https://www.ncbi.nlm.nih.gov/pubmed/23762567
http://dx.doi.org/10.1155/2013/130470

Ejemplares similares